Cohort-specific serological recognition of SARS-CoV-2 variant RBD antigens
Douglas D. Fraser, Michael R. Miller, Claudio M. Martin, Marat Slessarev, Paul Hahn, Ian Higgins, Christopher Melo, View ORCID ProfileMichael A. Pest, Nate Rothery, Xiaoqin Wang, Johannes Zeidler, Jorge A. Cruz-Aguado
doi: https://doi.org/10.1101/2022.01.10.21268250
Douglas D. Fraser
aLawson Health Research Institute, London, ON N6C 2R5, Canada
bDepartment of Pediatrics, Western University, London, ON N6A 3K7, Canada
cDepartment of Clinical Neurological Sciences, Western University, London, ON N6A 3K7, Canada
dDepartment of Physiology & Pharmacology, Western University, London, ON N6A 3K7, Canada
Michael R. Miller
aLawson Health Research Institute, London, ON N6C 2R5, Canada
bDepartment of Pediatrics, Western University, London, ON N6A 3K7, Canada
Claudio M. Martin
bDepartment of Pediatrics, Western University, London, ON N6A 3K7, Canada
eLawson Health Research Institute, London, ON N6C 2R5, Canada
Marat Slessarev
bDepartment of Pediatrics, Western University, London, ON N6A 3K7, Canada
eLawson Health Research Institute, London, ON N6C 2R5, Canada
Paul Hahn
fDiagnostics Biochem Canada Inc, London, ON N6M 1A1, Canada
Ian Higgins
fDiagnostics Biochem Canada Inc, London, ON N6M 1A1, Canada
Christopher Melo
fDiagnostics Biochem Canada Inc, London, ON N6M 1A1, Canada
Michael A. Pest
fDiagnostics Biochem Canada Inc, London, ON N6M 1A1, Canada
Nate Rothery
fDiagnostics Biochem Canada Inc, London, ON N6M 1A1, Canada
Xiaoqin Wang
fDiagnostics Biochem Canada Inc, London, ON N6M 1A1, Canada
Johannes Zeidler
fDiagnostics Biochem Canada Inc, London, ON N6M 1A1, Canada
Jorge A. Cruz-Aguado
fDiagnostics Biochem Canada Inc, London, ON N6M 1A1, Canada
Article usage
Posted January 11, 2022.
Cohort-specific serological recognition of SARS-CoV-2 variant RBD antigens
Douglas D. Fraser, Michael R. Miller, Claudio M. Martin, Marat Slessarev, Paul Hahn, Ian Higgins, Christopher Melo, Michael A. Pest, Nate Rothery, Xiaoqin Wang, Johannes Zeidler, Jorge A. Cruz-Aguado
medRxiv 2022.01.10.21268250; doi: https://doi.org/10.1101/2022.01.10.21268250
Cohort-specific serological recognition of SARS-CoV-2 variant RBD antigens
Douglas D. Fraser, Michael R. Miller, Claudio M. Martin, Marat Slessarev, Paul Hahn, Ian Higgins, Christopher Melo, Michael A. Pest, Nate Rothery, Xiaoqin Wang, Johannes Zeidler, Jorge A. Cruz-Aguado
medRxiv 2022.01.10.21268250; doi: https://doi.org/10.1101/2022.01.10.21268250
Subject Area
Subject Areas
- Addiction Medicine (381)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2832)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12530)
- Forensic Medicine (10)
- Gastroenterology (799)
- Genetic and Genomic Medicine (4407)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2837)
- Health Policy (1045)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (460)
- Neurology (4166)
- Nursing (220)
- Nutrition (615)
- Oncology (2194)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1169)
- Primary Care Research (481)
- Public and Global Health (6750)
- Radiology and Imaging (1484)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (365)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)